Lanreotide for Metabolic Health
Research, mechanism, dosing, and effectiveness of Lanreotide for metabolic health.
Quick Answer
Lanreotide is used for acromegaly and neuroendocrine tumor management.
Evidence Level
FDA Approved
Typical Dose
60-120 mg monthly deep subcutaneous
Results Timeline
Hormone control over weeks
FDA Status
FDA Approved
How Lanreotide Works for Metabolic Health
Long-acting somatostatin analog for hormone suppression.
About Metabolic Health
Improvement of metabolic markers including blood sugar, insulin sensitivity, and lipid profiles.
Research Evidence
CLARINET trial demonstrated tumor control in GEP-NETs. Noninferior to octreotide for acromegaly. Unique self-injectable deep subcutaneous formulation improves convenience. Extended dosing interval available.
Dosing for Metabolic Health
Recommended Dose
60-120 mg monthly deep subcutaneous
Frequency
Every 4 weeks (deep SC)
Administration
Deep subcutaneous injection
Duration
Long-term / chronic use
Note: Long-acting somatostatin analog. Somatuline Depot. Deep subcutaneous injection.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Diarrhea
- •Abdominal pain
- •Nausea
- •Injection site reactions
- •Gallstones
- •Hyperglycemia or hypoglycemia
Frequently Asked Questions
Does Lanreotide help with metabolic health?
Lanreotide is used for acromegaly and neuroendocrine tumor management.
How does Lanreotide work for metabolic health?
Long-acting somatostatin analog for hormone suppression....
What dose of Lanreotide should I use for metabolic health?
60-120 mg monthly deep subcutaneous
How long until I see results?
Hormone control over weeks
Other Peptides for Metabolic Health
These peptides are also researched for metabolic health.
Gonadorelin
FDAA synthetic version of gonadotropin-releasing hormone. Used diagnostically and therapeutically for various reproductive and hormonal conditions.
Pegvisomant
FDAA GH receptor antagonist that blocks growth hormone action. Used for acromegaly when surgery and somatostatin analogs fail to normalize IGF-1.
Macimorelin
FDAAn oral ghrelin mimetic used to diagnose adult growth hormone deficiency. The first FDA-approved oral GH stimulation test.
Oxytocin
FDAA naturally occurring peptide hormone crucial for social bonding, childbirth, and lactation. Being studied for autism, anxiety, and social disorders.
Educational Information Only
This information about Lanreotide for metabolic health is for educational purposes only. Always consult with qualified healthcare providers before using any peptide. Individual results may vary.